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6200 MD Maast r i ch t ,  The Nether lands .
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ABSTMCT
i^le have invesEigated the anti thronbin II I  independent effect of
crude heparin, tr^ro heparin fract ions and a heparinoid on in vitro
thronbin-induced platelet act ivat ion. Thrornbin-induced platelet
factor Va generation and thrornbin plus col lagen-induced platelet
prothrombin convert ing activi ty were tested. Crude heparin was a
more potent inhibitor of these reactions than the fract ions or the
heparinoid. The inhibitory action of the heparins was found to be
the result of a direct effect on thrombin and not of an effect
either on platelet act ivat ion functions or on the assembly or
functioning of the proEhrombinase complex. Probably this heparin
inhibit ion is due to the masking of secondary macromolecular sub-
strate binding sites on the thrombin molecule. We found no corre-
lat ion between IC.n values and the anti thrornbin II I-dependent
an t i th rombin  spec id i "c  ac t i v i t ies  o f  the  hepar ins .  Th is  suppor ts  the
not ion  tha t  hepar in  p roper t ies  o ther  than the i r  a f f in i t y  fo r  an t i -
thrombin II I  may contr ibute to the action of this drug in blood
coagu la t ion .
INTRODUCTION
Heparin is an effect ive anti thrombotic agent, widely used in the treatment
and prophylaxis of venous thrornbosis and thromboembolisrn. However, i- ts
c l in ica l  use  is  l in i ted  by  i t s  rna jo r  s ide  e f fec t ,  b leed ing .  Tor  many years '
i t  was general ly assumed that both the anti thrombotic and hemorrhagic
propert ies of heparin are related to i ts abi l i ty to augment the reactions
between activated coagulat ion factors and anti thrombin II I .  l" lore recentlyt
numerous comparative studies on the hemorrhagic, anti thrombotic and anti-
coagulant effects of heparinoids and low molecular weight heparin frac-
t ions ,  p repared f rom crude hepar in  by  a  var ie ty  o f  ne thods ,  ind ica te  tha t :
1) 1ow rnolecular weight heparins with an anti- factor Xa to anti- thrornbin
Key words : Thrombin, heparj-n, LMi, l  heparin, platelet coagulant act ivi t ies.
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ra t io ,  la rger  than tha t  o f  c rude hepar in ,  have s imi la r  an t i th rombot ic
a c t i v i t i e s  b u t  p r o d u c e  l e s s  h e m o r r h a g e  ( l ) , 2 )  T h e  a n t i - f a c t o r  X a  a c t i v i t y
o f  h e p a r i n  i s  n o t  r e l a t e d  t o  i t s  a n t i t h r o m b o t i c  a c t i v i t y  ( 2 , 3 ) , 3 )  T h e
excess  1ow a f f in lLy  mater ia l  p resent  in  hepar in  w i th  a  low a f f in i t y  to
anti thrombin II I  increases hemorrhage, without having either in vivo anti-
t .h rombot j .c  o r  ex  v ivo  an t icoagu lan t  ac t i v i t y  (4 )  and 4)  Derura tan  su l fa te ,
known to  po ten t ia te  on ly  the  ac t iv i t y  o f  hepar in  co fac tor  I I  on  th rombin ,
has an anti thrombot. ic act ivi ty equal to that of crude heparin but leaves
h e m o s t a s i s  l a r g e l y  u n a f f e c t e d  ( 5 ) .
These s tud ies  i l l us t ra te  the  d i f f i cu l ty  in  a t tempt ing  to  cor re la te  in
vit .ro assays and in vivo blood changes. I t  can be questioned whether one
has to  search  fo r  ocher ,  more  spec i f i c  markers  o f  the  an t i - th rombin  e f fec t
of heparin, that could be either an anti thrombin l l l -dependent or indepen-
dent one. In this contex! i t  is important to note that coagulat ion and
p la te le t  reac t ions  are  s t rong ly  coup led  by  a  pos i t i ve  feedback  mechan ism
because thrombin-induced platelet act ivat ion generates procoagulant act lvi-
t ies. This thrornbin-dependent mechanism leads to an important ampli f icat ion
of thrombin generation and so of both hemostatic plug and thrombus forma-
t  i o n .
The present. study was undertaken to determine to what extent heparin-
(fract ions) inhibit  the formation of thrombin-induced platelet procoagulant
ac t iv i t ies  and to  inves t iga te  whether  hepar in ( f rac t ions)  exer t  such an
anti-thrombin activi ty through a mechanism that is independent of ant. i-
th rombin  I I I .
MATERIAL AND METHODS
S 2238 (H-D-Phe-Pip-Arg-pNa) was purchased from AB Kabi Diagnostica,
Stockho ln ,  Sweden.  Fac ty  ac id  f ree  human serum a lbumin  ( l lSA) ,  Russe l l t s
Viper Venom and Echis Carinatus venom were obtained from Sigrna. I{orse
tendon col lagen was obtained from Hormon-Chemie Miinchen, Germany. l t  was
added in  the  non- f ib r i l l a r  fo rm d isso lved in  ac id lc  d i lu t ion  bu f fe r  ob-
tained from, Hormon-chemie. Reaction tubes were 2 mL plastic f lal-botton
tubes  ob ta ined f rom Ster i l in  L td  (Tedd ing ton ,  Eng land) .  Te f lon-coated
magnetic spinning bars 7x2 nm were fron Bel-Art products, USA. phosphati-
dy lcho l ine  (18 :1  c is /18 :1  c is  phosphat idy lcho l ine)  was f rom S igma,  USA.  A11
reagents  used were  o f  the  h ighes t  g rade commerc ia l l y  a .va i lab le .
Prepara t io l  o f  Phospho l ip ids  and Phospho l ip id  Ves ic les .  Phosphat idy lser ine
(18 :1  c is /18 :1  c is )  was  prepared f rom phosphat idy lcho l ine  by  enzymar ic
syn thes is  accord ing  to  the  method o f  Comfur ius  and ZwaaI  (6 ) .  S ing le  b i -
layer  ves ic le  so lu t ions  were  prepared as  prev ious ly  descr ibed (7 ) .  phospho-
f ip id  concent ra t ions  were  de ter rn ined by  phosphate  ana lys is  accord ing  to
B 6 t t c h e r  e t  a 1 .  ( B ) .
Pro te ins .  Bov ine  pro thrombin ,  fac to r  X ,  fac to r  Xa,  fac to r  V  and fac to r  Va
were  pur i f ied  accord ing  to  es tab l i shed procedures  (9 ) .  Hurnan and bov ine
o- th rombin  were  prepared as  descr ibed by  P le tcher  e t  a l .  (10) .  The spec i f i c
clott , ing activi ty was 2800 NIH U/rng for human throrobin and 2200 NIH U/nog
for  bov ine  th rombin .  The pro te in  p repara t ions  were  s to red  a t  -70  "C a f te r
d ia lys is  aga ins t  50  nM Tr is /HCl  175 rnM NaCl  a r  p I I  7 .9 .
Pro te in  Concent . ra t ions .  Concent ra t ions  o f  th ronb in  and fac to r  Xa were
@ i t e t i t r a t i o n w i t h p - n i t r o p h e n y 1 - p - g u a n i d i n o b e n z o a t e
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comple te  ac t iva t ion  r i i th  E .car ina tus  venom fo l lowed by  ac t ive  s i te  t i t ra -
t ion .  S i rn i la r l y ,  facLor  X  concent ra t ions  were  ob ta ined by  ac t ive  s i te
t i t ra t ion  a f te r  comple te  ac t iva t ion  w i th  fac to r  X  -  conver t ing  pro te in  f rom
Russe l l rs  v iper  venom ( l l ) .  Fac tor  Va concent ra t ions  were  de t .e rmined by
k i n e t i c  a n a l y s i s  ( 9 ) .
Heparj-n and Heparin Fractions. Crude porcine intest inal mucosal heparin (MW
1500-30000,  mean MW 15000,  an t i  Xa  and an t i  I Ia  ac t i v i t y  175 U/ rog)  i , ras
obta ined f rom Organon Labora tor ies  (0ss ,  the  Ne lher lands) .  The fo l low ing
1ow molecular weight compounds were prepared from standard heparin by Choay
Ins t i tu te  (Par is )  t  CY 2L6,  a  ca lc ium sa l t  was  ob ta ined by  e thano l  ex t rac-
t ion  (nean MW 4500,  USP ac t iv i t y  50  U/ rng ,  an t i  Xa  ac t iv i t y  200 U/mg,  an t i
I Ia  ac t i v i t y  10-20  U/ng)  and CY 222,  a  sod ium sa l t  was  ob ta ined by  n i t rous
ac id  depo lymer iza t ion  (nean MW 2500,  USP ac t iv i t y  25  LJ /mg,  an t i  Xa  ac t iv i t y
250 U/ng,  an t i  I Ia  ac t i v i t y  S-15  U/mg) .  Org  10172,  a  su lphated  nucopo ly -
sacchar ide  was iso la ted  by  Organon Labora tor ies  (Oss ,  the  Nether lands)  f rom
porc ine  in tes t ina l  mucosa ( rnean I4W 6400,  USP ac t iv i t y  2 .94  IJ /mg,  an t i  Xa
ac t iv i t y  8  U/ng ,  an t i  I Ia  ac t i v i t y  O. :2  U/mg) .
Isolat ion of I luman Platelets. Blood was drawn by venepuncture from healthy
male volunLeers who had not taken any medication for at least one week. As
ant icoagu lan t ,  one vo lume o f  ac id  c i t ra te /dex t rose  (0 .18  M g lucose/O.O8 M
sod iurn  c i t ra te /0 .052 M c i t r i c  ac id )  was  added to  5  vo lumes o f  who le  b lood.
P la te le t - r i ch  p lasma was ob ta ined a f te r  cen t r i fug ing  aL  22oxg fo r  15  n in .
Platelets were isolated by centr i fuging at 600x9 for 20 min and the pel1et
r ras  resuspended in  a  Hepes bu f fe r  con ta in ing  136 mM NaC1,  2 .68  mM KC1,  2  mM
l ' lgC l r r  10  mM Hepes,  5  mM g lucose ar rd  0 .47"  HSA,  pH 6 .7 .  The p la te le ts  were
wash6d tw ice  in  th is  bu f fe r  by  cent r i fug ing  350xg,  15  rn in .  Before  cent r i -
fug ing  ac id  c i t ra t .e /dex t rose  was added to  the  suspens ion  ( l  vo l .  to  14
vo1. ) .  F ina l l y  the  p la te le ts  v rere  resuspended in  the  Hepes bu f fe r  a t  pH 7 .5
conta in ing  0 . I7 "  HSA.  The en t i re  p rocedure  fo r  p la te^1et  p repara t ion  took
about  2h  and was car r ied  ou t  a t  room tempera ture  (22  "C) .  P la te le t  concen-
trat ion was determined with a Coulter counter. Platelets were kept at room
temperature and no loss of platelet functions was found for at least l5h.
D e E e r n i n a t i o n  o f  P l a t e l e t c t o r  V  R e l e a s e  a n d  A c t i v a t i o n .  2 9 2  p l  o f
p l a r e l e t  s u s p e n s i o n  ( 5 . 5  x  1 0
449
l r le t  s ion   - /n f )  were  incubated  w i th  13  iL1  o f  75  mM CaC1"
and st i-rred (350 revolut ions/nin) for 3 min at 37 "C fol lowed by the addi:
t ion  o f  th rombin ,  resu l t ing  in  a  f ina l  vo lume o f  350 p1 .  Subsequent ly ,
a l iqgo ts  (usua l ly  20  p1)  were  taken and incubated  w i th  fac to r  Xa (1 .3  x
10 " M), phospholipid^contai-ning 20% phosphatidylserine and 80% phosphati-
dy lcho l ine  (1 .0  x  f0  "  M)  and CaCln  (10  m1 ' { )  in  a  bu f fe r  con ta in ing  50  nM
Tr is ,  i75  mM NaCl  and 0 .5  ng /n1  HSAI  p I I  6 .7  in  a  f ina l  voh lme o f  0 .225 mL
for  5  min  a t  37  "C in  a  p las t i c  cuvet te .  Theo reac t ion  was in i t ia ted  by  the
add i t ion  o f  25  p l  o f  p ro th rombin  (2 .0  x  10  "  M) .  A f t .e r  2  mi .n ,  0 .65  n l  o f
the same buffer containing 20 nM EDTA artd 0.24 pmol 52238 was added to the
reaction nixture. The anoount of thrornbin formed was measured by the change
in absorbance recorded on an Aninco DW2 spectrophotometer operating in Ehe
dua l  wave- length  mode (  r -=405 nm and L  -=500 nm)  Lhermosta ted  a t  37  
-C.
Standard curves were const.ructed by assal ing di lut ions of a bovine factor
Va preparation whose concentral ion was delermined uti l iz ing actir19, si te
t i t rahgd facEor  Xa (9 ) .  The assay  had a  func t iona l  range f rom 2x l0  " -  Iu l  to
l x l 0  
^ -  M  o f  f a c t o r  V a .
Platelet Beta-Thromboglobulin (BTG) Rglease. To a reaction tube contalning
13 i r1  o f  75  m- l ' l  CaC1,  was added.
The tube content was st irred for 5 min at 37 "C and platelet acEivation was
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V o l . 3 8 ,  N o . 5
Derermination of Platelet,Prothronbin Convert ing 4c!lvi ly 
( .  2 9 2  v L  o f
started by addit ion of a platelet.  act ivator 
(thrornbin or col lagen) re,sult-
i n g i n a f i n a l v o l u m e o f 3 5 0 u l . A f t e r a v a r i . a b l e t i m e p e r i o d e a t 3 T - . " C ,
E.he release reaction was stopped by adding to the 
platelet suspension 56 u1
i{epes buffer conraining 135 
-mU_toinaraehyde, 
100 mM-EDTA, and bringing i t
to a nelt ing ice-uatt i  ( tz).  
platelets were centr i fuged for I  rnin in an
Eppendorf centr i fuge 5412, 2OO lr l  of Lhe supernatant 
was careful ly removedt
t o w h i c h 5 0 p l o f a 2 l " l T r i s s o l u t i o n w a s a d d e d t o n e u t r a l l z e t h e e x c e s s o f
f o r r n a l d e h y d e . T h e s . ' p l e w a s d i l u t e d l : 3 i n H e p e s b u f f e r p H T . 5 c o n t a i n i n g
2 0 l z o f h o r s e s e r u m " , , d t t ' " a m o u n t o f B T G w a s m e a s u r e d u s i n g t h e B T G ' r a d i o -
inmunoassay kit  from Amersham International Limited 
accordi-ng Lo the in-
struct ion of che manufacturer '
thrornbin or col lagen plus thrombin result ing in 
a f inal volume of 325 ul
and a .CaC1^ concentiat ion of 3 nM. Mter a variable t irne of 
st irr ing at 37
6a- t i . . . " ;1 ; i " ;  t . igg . .  t i roe)  the  ppcA was de le rmined as  fo l lows.  
50  u l
facror va (5nM) and 5-0- u1 factor xa (10 nl ' l )  were 
added to the tr iggered
platelet suspension, to a11ow equil ibrat ion with the 
platelets'  After 2 min
period of preincubaiion, prothronbin activation was started 
with the addi-
t i o n o f 7 5 u 1 o f . p , u p . ' . d m i x t u r e c o n t a i n i n g 6 . 6 u } 4 p r o t h r o m b i n a n d 2 T m ,  
1
CaCl. in 50 mM rr iJ, 
- iZS 




of 0.5 m1. The f inal_ concentrat ions of the reactants 
were: 0.5
nIuI facror Xa, I nl'I factor Va, I pM Prothronbin and 6 
nl"l CaCLr' Aft.e1 39- a:tl
aO ; al iquois t""""f1y 10 u1) w&e taken from 
the reaction mixture to
determine the amount of thrombin formed'
of 75 rnM CaCl'  and
p1.8"1 . t  
" " "p . "s ion  
(5x10" / ro1)  were- in
st irred for 3 min at 37oC' Platelet st imulat ion 
was started- 
f l  I 'U.Ut19
Analysis of the Data. we,assumed that thrombin forms 
a complex with heparin
a n d t h a t s u c h a c o m p l e x h a s n o e n z y n a t i c a c t i v i t y . T h e r e v e r s i b l e a s s o c i a _
tion between heparin and thrornbin is expressed as:
K.  =  tH l  l r ra )  / [n . r ra ]  
(  1 )
d
w h e r e [ I t ] i s t h e f r e e h e p a r i n c o n c e n t r a t i o n a n d [ r t a ] i s u n c o m p l e x e d t h r o m *
bin. Because heparin is present in excess over thrombin, [ I{ l  
can be equaled
t o t h e h e p a r i n c o n c e n t r a t i o n a d d e d . S i n c e t h e i n i t i a l r a t e o f f a c t o r V a
g e n e r a t i o r r ( v ) i s d i r e c t l y p r o p o r t i o n a l t o t h e u n c o m p l e x e d t h r o m b i n c o n c e n -
trat.  ion:
v  =  K [ I r a l
w h e r e  [ i l a ] -  i s
" or l n c :
=  k ( t r r a l o  -  [ ] t . r r a l )  
( z l
the init ial  thrombin concentrat ion' Fron 
( l)  and (2) we
( 3 )
. ' / ( v o - t )  =  K d . ( 1 / t H l )
where  v^  =  k [ I la ]^ ,  i s  the  in i t ia l  ra te  o f  fac to r  
Va genera t ion  in  Lhe
absence-of heparing'e ptot of v/(v^-v) versus the 
reciprocal heparin con-
centrat ion gives 
" "a.I igtt  
- i in. 'w?ttt '  
slope KU. S_ince K, is the amount of
hepari-n required to bind half the thronbin, t f te KU 
valot can also be ex-
pi!"".a as rCro, the amount of heparin causing 50 %* inhibit ion'




nttt t l : t"";*dy 
the effecrs of heparin and hepar_ir* fracrions 
on rhe inir ial
rate of platelet f ; ; ; ; t  Va generation' 
4'6 
" 
t-0" plat-elets/ml were st imu-
l a t e d w i t h O . 5 n M t h r o m b i n a n d t t , e a n o u n t o f f a c t o r V a f o r m e d w a s d e t e r -
r o i n e d b y a s s a y i n g s a ' p l " s t a k e n 3 m j . n a f t e r i n i t i a t i n g t h e r e l e a s e . I t i s
important to note rhai under these condit ions 
the rate of factor va genera-
t i o n i s p r o P o r t i o n a l t o t h e f u n c E i o n a l t h r o m b i n c o n c e n t r a t i o n ( F i g u r e l ) .
I n h i b i t i o n  o f  P f . t . f " t  f " " t o t  V , n
i#+t##*=??1,, ".1".'?tl.i"-. 
"=.-"""1"* 
wr,en rtronnuin is present (13,14)'
- - ^ ^ ^ ^ - ^ n +  ^ f  t l r a
fi l"uL'li i i i; ;;; '.", assay is virrually a quanrirarive 
assessmenr of rhe
, - l ^ *  * L ^  d d d .
;:"H::-'J=;"".;:; ;"' ;;fJ'.r"".f3"1J' y i"^'^'-:'-tt;.t:i;,I?::','i:".;"::l
:ffiffH:":'r'#""",' ;';J;;;; JJ--r.i z "t 
racror Va activitv (data not
. -  ^ t + ^ *  + r i c c o r i n q
:;:H;:H"'i"'iJt"t.,utu or ractor va actlvitv c'":Ii:1i"-:::":-:':g:::l?:
:il';i;.:i!."","iii'.i.g'ui", -"fp."'.a :: f^.?l-'n::'l:::l-T:n.;l: :::ilt;::H"H:IJH :;";""ffi ffi niJ-t;;l';i. "::;*. :l- 'il"'"*:i :i":':?ilX ::;:ffiIll"il" #";. i "vl|t i..;:" ti'::'::" tTlg"::^l);"lil,';"iil11il,:::;:'ffi::h-:i iili!ri."?'""i..^u^i..Iy-"t ar-. (15j reported ror rriton-lvzeir
FIG.  I
Effect of varyi-ng thrombln concen-
trat ions on the t ime course or
fac to r  Va genera t ion .  A ,  P la te le ts
(4 .6^  x  10o/n1)  were  incubated  a t
37 "C wit.h varYing thronbin con-
c e n t r a t i o n s  ( A ,  0 . 1 2 5 n M ;  t r  '
, 0 . 2 5  n M ;  I  ' 0 . 5  n M ;  A , 0 . 7 5  n M ;  
O  ' 1
n M ;  O , 1 . 5  n M ) .  B ,  r e P l o t  o f  t h e
init ial  rate of factor Va forua-
t ion as a function of thrombin






























T h e i n f r u e n c e o f v a r y i n g a m o u n t s o f c r u d e h e p a r i n r c y 2 1 6 , c Y 2 2 2 a ' t l d
0rg 10172 on the init ial  
-r ie 
of factor va generaLion is shown in Figure
2 A ' . l t i s a p p a r e n t t h a t . r u d e h e p a r i n i s t h e m o s t p o t e n t i n h i b i t o r . W h e n
t h e d a t a f r o m F i g u r e 2 A w e r e r e p l o t t e d a c c o r d i n g t o E q u a t i o n l - ( " . u u
l"laterials and Methods) straight u-nes were 
obtained going through the
t ime, min
@
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E f f e c t o f h e p a r i n ( f r a c t i o n s ) . o n . . t h r o m b i n i n d u c e d p l a t e l e t f a c t o r V a
generarion. plaretets-i ; : ; ;  lbb/d) 
*"r"-" l i t .ud with 0.5 nl ' l  human 
throm-
b i n f o r 3 m i n r i - n t h e p r e s e n c e o t t ' " r y i " g c o n c e n t r a t i o n s o f h e p a r i n ( O ) t
c . I  2L6 (  O ) ,  c ' I  222  (  a  ) ,  o r  o rg  
rc l l z -  (  r  ) '  A ' ,  percentage o f  
res idua l
faclor va activj-ty 
-"" '  
"  
' i , r .r"aroi 
of trepai in concentrat ions. B, 
replot ot
t h e d a t a a c c o r d i n g t o E q u a t i o n 3 a s d e s c r i b e t l i n R e s u l - ' t s . 1 0 0 % f a c t o r V a
acrivi ty in rhe absence of heparin 
r"JJ n*-;tor va ( lprn va' 
rnin - l) '
or igin (Figure 28). Thus, our assumption 
that the inhibit ion is caused 
by
the formation of t l"-  i tptt in-thronbin 
complex appears to be an acceptable
minimal hypothesis.-trr" icro values, 
." u"i fu"tud-ftot Figure 28, are 
given
t" t"ht""t"uta 
.xcrgae the invorvement of antithrornbin 
rrr in the reaction'
when platelers (ro7lrr) ' . re srimulated 
with 5 nM thrornbin in the presence
o f c r u d e h e p a r i n ( 1 0 u e / n ] . ) n o l o s s o f t h r o D b i n a c t i v i t y t o w a r d s S 2 2 3 3 w a s
observed over " 
zo- i io r ir" periodl in-adait lon, 
i t  was veri f ied thal
h e p a r i n o r h e p a r i n f r a c t i o n s h a d n o e f f e c t o n t h e f a c t o r V a a s s a y . W h e n
h e p a r i n ( f r a c t i o n s ) a t a f i 1 5 r l - c o n c e n t r a t i o n o f 0 . 5 n g / n l w e r e a d d e d t o a
plateter suspensr_on iA.O*fOblrf l  in;ated 
for 15 roin in the presence of
0 . 5 n M t h r o m b i n , . t , . . ' " ' " l e v e l o f f a c t o t v a a c t i v i t y w a s m e a s u r e d a s i n
.n" 
??"'ff;r".li:iill' ,." replaced by bovine throm'bin, 
rhe klnetics :t
bovine ttrrontin-induced plateiet 
facror Va generation were found 
to be
i d e n t i c a l t o t h o s e r e p o r t e d t ' . r " . t o r h u m a n t h r o n r b i n ( d a t a n o t s h o w n ) .
I lowever, the lc.n ""r"" '"  
for the dif ferent heparins are signif icantly 
lower
rhan rhose tor 
'1irrrrn ihrombin (Tabl; r i) .  t tr is l"-- io 
accordance with the
higher aff inty oi-t .p.r ir  for bovi ie 
i i r .o*tr l l  (16) and supports the 
idea
that the heparins 
-int&act 
prirnarily with the thrombin'
Effecr of Hep-Tin 01 p-1?:r--+r::B?1?--f,lronb,oqlo;b:u#n:+,eTase' 
rn order to
investigate i-r any interaction oetweEnlfE 
and h6i-arin' might result
in an j-npaired rel_ease reaction, r" "i"a'i.J 
th9 release tf another platelet
alpha-granor" ptot"i", src' 
prtt"r"t""i lJ" l i l l tr l were incubated with l0
ug collagenlrr or-ri i i  o.s 
ola thronbiri ' ; i";;; i-n tte absence or 
presence of
crude heparin (0'1 mg/rnl) ' When 
platelets were stimulated by collagen'
@
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hepari-n had no effect on t.he kinetics of BTG release,
pg / rn l )  d imin ished BTG re lease to  less  rhan IOZ o f
th rombin  was used to  s t imu la te  the  p la te le ts .
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whereas heparin ( 100
the  cont ro l  va lue  i f
E f f e e t  o f  H e p a r i n  a n d  H e p a r i n  F r a g m e n l s  o n  t h e  G e n e r a t i o n  o f  p l a t e l e t
Actili_t.y .in Prothrolnbi" A-
ty  (F  d i t ions  where  added fac to r  Va exceeded
greatly the amount of factor Va that was generated from platelets, so as to
make the test independent of factor v release. By omnit ing phospholipids
from our assay, the rate of thrombin formati.oo beco*.s direct ly propor-
t ional to the amount of procoagulant surface that. was generated upon
platelet st imulal ion. rt  has been shom that platelets act ivated by a
conbination of col lagen plus thrornbin form a more suitable catalyt ic
surface for the prot.hrornbinase complex then plalelets treated with thrombin
a lone ( t11 .  There fore ,  we inves t iga ted  the  e f fec t  o f  hepar lns  on  human
thronbin plus col lagen-induced PPCA. Condit ions had to be found where ppCA
generation is l inear i .n t ime and direct ly proport ional to the thronbin
concentrat ion. The generatioq of a procoagulant surface was fol lowed in
t ime fo r  p la te le rs  (4 .6  x  io " /ml )  s r imu lared  w i th  th rombin  (0 .3  nM)  p lus
co l lagen (5  ug /ml )  (F igure  3) .  The dependency  o f  p la te le t  ac t i va t ion  on  the
thrombin concentrat ion is shown in Figure 4, either in the absence or
presence of 5 ug/m1 co11agen. As a standard procedure to study the effect
of heparin, platelets were st imulated for 3 rnin with 0.3 nM t-hrornbin plus
5 ug/*1 col1agen. Although col lagen had to be added in order to potentiate
the PPCA generating eff iciency of 1ow thrombi-n concentrat ions, i t  has t.o be
mentioned that under these condit ions the rate of ppcA generation is
d i rec t l y  p ropor t iona l  ro  the  th ronb in  concent ra t ion  (F igure  4) .
-u ,F igure  5  dep ic ts  the  resu l rs  o f  e4per iments  where  p la te re ts  (4 .6  x
10- /ml )  were  incubaced fo r  3  min  a t  37"C i ^ r i th  vary ing  concenLra t ions  o f
c rude hepar in ,  cY 216,  cy  222 or  o rg  10172,  fo l lowed by  the  s r imu la t i -on  o f
platelets during 3 rnin and measurement of prothrombin convert ing activi ty.
I t  is interesting to see that crude heparin is not able to block cornpleteiy
the generation of prothronbin convert ing aetivi t .y. Apparently, the re-
maining activi ty is equal to that generated by col lagett in th. absence of
thronbin. rndeed, in a separate experiment we found that neither crude
h e p a r i n  n o r  h e p a r i n  f r a g m e n t s  w e r e  a b l e  t o  b l o c k  t h e  f o r m a t i o n  o f
col lagen-induced PPCA. 
Icso values were derermined by anaLyzing the dataas described in Materials-"and Methods. The replot of the data irorn f igure
5A according to Equation 3 1s shown in Figure 58. The intercept on the
ver t i ca l  ax i -s  represents  the  f rac t ion  o f  the  ppcA ac t iv i t y  genera ted  by
co l lagen a1one.  The ICan va lues  are  l i s ted  in  Tab le  I .
u n d e r  c o n d i t i o n s " " w h e r e  t h e  p r o c o a g u l a n t .  s u r f a c e  i s  t h e  l i m i t i n g
component of rhe prothrombinase complex, heparin might have as well  an
ef fec t  on  the  assembly  o f  the  conp lex  and so  a f fec t ing- the  ppcA assay  (17) .
However, when heparin or heparin fract ions r^rere added to col lagen plus
thrombin st imulated platelets no decrease in PPCA was observed, indicai ing
tha t  hepar in  exer ts  so1e1y an  e f fec t  on  the  genera t ion  o f  ppcA ( r ru ru  r r r ) I
Human thrombin plus col lagen acting on human platelets requires more
heparin or heparin fract ions to attain 50% inhibit ion of ppcA than bovine
thrombin  does  in  the  presence o f  co l lagen (Tab1e I I ) .
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. TABLE I
Effect of Heparin Fractions on Human Thronbin-Induced Factor Va Generatlon



















Ef fec t  o f
TABLE II
I leparin Fractions on Bovine Thrombin-Induced Factor Va Generation














9 0 . 0







I leparin Addit ion on the Thrornbin Plus Collagen-Induced
Procoagulant Prothrombin Convert ing Activi ty
Compound







c\  222 (1000





2 4 . 0
2 4 . 0








HEPARIN AND PLATELET ACTIViTY V o l  . 3 8 ,  
N o . 5
456
DISCUSSION
The heparin preparations that are in 
general use--at this moment are
e x t r e m e l y c o m p l e x m i x t u r e s w i t h " o ' p o ' , . , , t . t h a t d i f f e r w i t h r e s p e c t t o
molecular weight, 
"f ' t t i t" f  
cornposit ion' secondary structures as 
well  as
a n t i t h r o r o b i n l l l a f f i n i t y a n d o t h e r b i o l o g i c a l p r o p e r t i e s . I t i s n o t
s u r p r i s i n g t h a t ' b e s i d e s t h e w e l l k n o w n a n t i t h r o n b i n l l l p o t e n t i a t i n g
effect many other inhibitory actions 
on the haemostatic system can 
be
f o u n d . C r u d e h e p a r i n s h o l . r s a m a r k e d a n t i c o a g u l a n t a n d a n t i t h r o m b o t i c ' b u t
a l s o a h e r n o r r h a g e - i n d u c i n g e f f e c t . ' I t w a s g e n e r a l l y a s s u m e d t h a t t h e s e
rhree effects were i" i i r"aEry l inked.- l"Iore 
reiently i t  has been shown that
these three biol-ogi-al functions of 
crude heparin can to a large extent 
be
d issoc ia ted  (1 -5) . - i t i "  " , rgg .s ts  
tha t  d i f fe ren t  f rac t ions  o f  c rude hepar in
c a n h a v e d i f f e r e n t e f f e c t s a s t o a n t i c o a g u l a t i o n ' a n t i t h r o m b o l i c a c t i o n a n d
t h e i n d u c t i o n o f h e m o r r h a g e s . T h i s i s e x t r e r n e l y i n t e r e s t i n g a n d o f g r e a t
p r a c t i c a l i n t e r e s t b e c a u s e , w h e r e a n t i t h r o m b o t i c a c t i o n i s p u r s u e d a n d
h e m o r r h a g e m u s t o e a v o i d e d , t h e t h e r a p e u t i c r a t i o b e t w e e n t h e t w o a c t i o n s
is always estiurated on basis of anticoagulant 
act ion'
I {owever '  the  re la t ionsh ip  be tween 
j -n  v i t ro  k ine t ics  as  assessed by
c lo r t ing  assays  " rd - ; ; ; " t i th rombot ic - " . t ion  
o f  hepar in  i s  fa r  f ro rn  be ing
u n d e r s t o o d . A l t h o u g h b i n d i n g t o a n t i t h r o r o b i n l l l p l a y s a n i m p o r t e d r o l e i n
t h e  a n t i t h r o m b o t i c  a c t i o n  o f  h e p a r i n '  
l o w - a f f i 1 1 t ^ {  h " p u t i n  s e e m s  t o
cont r ibu te  to  Lhe an t i - th rombot ic  ac t ion  
o f  hepar in  (19) '
A l t h o u g h p l a t e l e t s a r e e s s e n t i a L t o t h e i . o " " " . o f b l o o d c o a g u l a t i o n '
no data are avai labie on the effects oi 
t .prr i tr  or heparin fract ions on the
g e n e r a t i o n o f p t a t e l . t p r o c o a g u l a n t a c t i v i t i e s . T h e p r e s e n t s t u d y w a s
under taken to  assess  th ;  e f fec ts  o f  c rude 
hepar in '  d i f fe ren t  hepar in
f r a c l i o n s a n d " f , . p t t i " o i a o n t h r o m b i n - i n d u c e d p l a t e l e t f a c t o r V a g e n e -
rat ion and throrobin plus col lagen-induced 
platelet prothronbin convert ing
acr iv i t y  (PPCA) .
Heparin IC5! values t:".  determined under 
condit ions where both
in i t ia r  ra tes  or lp la te le t  fac to r  va  and 
p la te le t  PCA genera t ion '  I te re
d i r e c t l y p r o p o r t i o n a l t o t h e t h r o m b i n c o n c e n t r a t i o n . T h e a s s u m p t i o n w a s
m a d e t h a t t h r o m b i n , w h e n c o m p l e x e d w i t h h e p a r i n , h a s n o a c t i v i t y t o w a r d s
m a c r o m o l e c u l a r s u b s t r a t e s . O u r e x p e r i m e n t a l d a t a a p p e a r t o b e c o n s i s t e n t
\. t i th that rnodel (Figures 2D and 58)'
An j-nteresEang observation was the absence 
of effect of heparin
(fract ions) on the assernbly and functioning of the 
prothrombinase complex
at  the  ou ter  membrane o f  ac t i va ted  p la te le ts  
(Tab le  r r r ) .  Th is  seems to  be
in  conr rasr  w i tn  i t re  f ind ings  o f  Wt i f . " t  
e t  a1 .  (18) 'They  repor ted  tha t
heparin inhibited prothrombin activation 
by preventing the binding of
ac t iva ted  c lo t t ing  fac to rs  as  we l l  as  
p io th rornb in  io  a  phospho l ip id
surface. when we performed equil ibr iurn binding 
studies according to van de
waarr er al.  (20) vre found thar cruJe 
hepari i  (1OO fg/ml) did oot change
the  a f f in i ry  o f  fac to r  va ,  fac ror  xa  anJ  
pro thrombin  to  phospho l ip id  as
well  as total phospholipids binding capacity 
(to be .publ ished) 
'
T h r o r n b i n _ i n d u c e d p l a t e l e t t u . t o ' V a - g e n e r a t f o n i s t h e r e s u l t o f
r e l e a s e  o f  t h e  n o n - a t t i v a t e d  f a c t o r  
a n d  s u b s e q u e n t l y  a c t i v a t i o n  b y
thrombin .  Because our  fac to r  Va "ssay  
i "  insens i t i ve  fo r  fac to r  v  the
inh ib icory  ac t ion  o f  hepar in  on  the  r . i " " " .  
reac t ion  cou ld  no t  be  separa ted
f rom i ts  ac t i_on on  th iombin-ca ta lyzed 
fac to r  v -ac t iva t ion .  I lowever t  we
demonstrated that heparin aia intr i l i t  
the thrombin-induced beta-thrombo-
globul i '  , .1.""e-, , t !r . ."  heparin did not inhibit  
the col lagen-induced
b e t a - t h r o m b o g l o b u l i n r e l e a s e . T h i s s u p p o r t s t h e n o t i o n t h a t h e p a r i n e x e r t s
i t s e f f e c t t i r r o l r g h - " - h e p a r i , ' - t h r o m b i n r a t h e r t h a n t h r o u g h a h e p a r i n -
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A s t o t h e I C . ^ v a l u e s m e a s u r e d f o r t h e d i f f e r e n t h e p a r i n s i n t h e t w o
.rr.ori i rr j i rrJ,r.uJ-i9.. .r".  reactions, i t  is obvious that 
for crude heparin
relat ively low IC.n values were found, compared to, CY 216' 
CY 222 and Otg
IOVZ.  There fore , '8 r ,  "  
r . ighr  bas is  (pg /n l )  c rude-  hepar in  i s  a  more  
po ten t
inhibitor of both factor Va and PCA geierat ion. The inhibitory 
capacity of
a h e p a r i n f r a c t i o n o n t h r o m b i n i n d u c e d r e a c t i o n s o f p l a t e l e t a c t i v a t i o n i s
n o t a l w a y s i . n a c c o r d a n c e w i t h i t s a n t i t h r o m b i n l l l - d e p e n d e n t a n t i t h r o m b j . n
specif ic act ivi ty iu"ai-rr" U/rng)'  l" loreover when 
ICro- values are given in
ant i - I Ia  U/n1r  no  cor re la t ion  is  found '  Th is  s t rodg" ly  
suggests  tha t ' - in
s t u d y i n g t h e i n h i b i t o r y a c t i o n o f . h e p a r i n o n t h r o m b i n ' a n a n t i t h r o m b i n
rl l_ieplndent effect "un 
b" dist inguished from an independent one.
A s y e t ' w e c a n o n l y s p e c u l a t e a b o u t t h e o c c u r r e n c e i n d i f f e r e n t h e p a r i n
rnolecular species, of "rr.r ,  
dif ferential anti thrombin actions' I t  would be
i n t e r e s t i n g t o e s t a b l i s h w h e t h e r o r n o t l o w - a f f i n i t y h e p a r i n s h a v e a n t l _
thrombin activi t ies in platelet reacl ions as studied in 
the present report '
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